title: All patients with inflammatory bowel disease should have bone density assessment: pro.
abstract: Bone loss is a common problem for individuals with inflammatory bowel disease. Corticosteroids play an important role in the development of osteoporosis in these patients; however, active disease and longer disease duration also appear to increase the risk of osteoporosis. Given the current burden of osteoporosis, bone mineral density is recommended.
authors.affiliation: Division of Geriatric Medicine, McMaster University, Hamilton, Ontario, Canada. papaioannou@hhsc.ca
authors.forename: A
authors.initials: A
authors.lastname: Papaioannou
authors.forename: N C
authors.initials: NC
authors.lastname: Ferko
authors.forename: J D
authors.initials: JD
authors.lastname: Adachi
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000328:Adult; D015519:Bone Density; D002648:Child; D018849:Controlled Clinical Trials as Topic; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000503:physiopathology*; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000503:physiopathology*
chemical_list: D000305:Adrenal Cortex Hormones